SLC27A5 and cancer: For example, SLC27A5 is downregulated in HCC, enhancing sora-induced ferroptosis by inhibiting the NRF2/GSR pathway in cancer cells, presenting a potential therapeutic approach to overcome sora resistance (Xu et al. 2023).